Nanalysis Announces Fourth Quarter and Full Year 2025 Results

Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million

Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand

CALGARY, AB, April 8, 2026 /PRNewswire/ – Nanalysis Scientific Corp. („the Company“, TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces its financial results for the fourth quarter and full year ended December 31, 2025. Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Heather Kury will host a conference call at 10 A.M. Eastern Time tomorrow, April 9^th, to discuss the results. All interested parties are invited to join these calls.  All dollar figures in this press release are in thousands of Canadian dollars, except per share amounts or unless otherwise stated.